Brent Sorrells, senior director of clinical operations at ZS Pharma, explains the decision to adopt Veeva Vault eTMF, the system’s advantages during acquisition activity, and how his team built a business case for its eventual parent company, AstraZeneca, to also adopt Vault eTMF.
More Customer Stories
Getting the Most out of Veeva Vault eTMF
Explore the Strategy
Explore the Strategy
Is It Time to Bring Your TMF In-House?
Discover the Benefits
Discover the Benefits
GBT's Journey to Strategic TMF Management
Learn From Their Success
Learn From Their Success